This content is machine translated "Patients W.A.I.T. Indicator" Access to new drugs is becoming increasingly difficult Switzerland is slipping further down the European rankings when it comes to access to new innovative medicines: according to IQVIA’s EFPIA WAIT Indicator 2024, Switzerland has dropped another place, falling...…
View Post 8 min This content is machine translated ASCO 2025 Supportive therapies for greater adherence and compliance ASCO 2025 is the annual meeting of the American Society of Clinical Oncology (ASCO), which took place in Chicago from May 30 to June 3. In this section, we take...…
View Post 6 min This content is machine translated Kidney Cancer From tumor biology to innovative therapies Renal cell carcinoma (RCC) is one of the most aggressive urological tumors worldwide. Despite significant advances in molecular characterization and therapy, the disease remains clinically challenging due to late diagnosis,...…
View Post 3 min This content is machine translated Precision therapy Targeted MET inhibition after progression with osimertinib Despite the success of osimertinib, a third-generation EGFR-TKI, in first-line therapy, the treatment of NSCLC after progression remains a challenge. SAVANNAH and ORCHARD have investigated the targeted addition of additional...…
View Post 4 min This content is machine translated Case Report An unusual reason for gastrointestinal bleeding The cause of gastrointestinal bleeding is not always easy to find. This case study is about a patient with massive gastrointestinal bleeding associated with a rare malignant disease of the...…
View Post 3 min This content is machine translated Immunotherapy Subcutaneously or intravenously? New data on the efficacy of subcutaneous immunotherapies versus intravenous therapies in NSCLC underline not only the benefits for patients but also for healthcare professionals. This is shown by analyses...…
View Post 0 min This content is machine translated Inoperable NSCLC Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy ... Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post 4 min This content is machine translated From symptom to diagnosis Oncology – Prostate carcinoma The causes of prostate cancer are still largely unknown. Age and hormones are considered to be the most important risk factors. Specific procedures are available for sonographic and magnetic resonance...…
View Post 3 min This content is machine translated De-escalation strategies De-escalation strategies – less is more Drug de-escalation is primarily driven by the need to spare patients unnecessary toxicity and the associated side effects and repeated hospital visits. However, de-escalation strategies may also have the potential...…
View Post 0 min This content is machine translated Advanced NSCLC MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC ... Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post 13 min This content is machine translated Focus on prevention Colorectal cancer screening – an update Colorectal cancer is a relevant disease for society: every twentieth person in Switzerland is affected at least once in their lifetime. In Switzerland, around 4300 new cases occur every year...… CME-Test
